NEW ORLEANS — Extracorporeal shockwave lithotripsy, once the gold standard for removing smaller kidney stones, has fallen out of favor, in part because it might be less effective than ureteroscopy, ...

In children undergoing ESWL, adjunctive α1-blocker therapy enhances the stone-free rate and reduces the stone expulsion time. Children with urolithiasis who receive adjunctive α1-blocker therapy after ...

Typical balloon placement and pretreatment sites relative to pacing/defibrillation leads. Photo Credit: J Am Coll Cardiol EP. Central Illustration (adapted). Pacemaker and defibrillator leads encased ...

Add Yahoo as a preferred source to see more of our stories on Google. Kevin Wininger, a computed tomography technologist and cardiovascular technologist at University Hospital’s Samaritan Medical ...

The demand for lithotripsy procedures is expected to increase in the coming years. This expected increase is supported by a review of the Global Lithotripsy Devices Market. It is forecasted to grow at ...

Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this condition Abbott's investigational Coronary ...

Q: Which Doctor Should I Consult for ESWL or Lithotripsy? A: Consult Urologist if you need ESWL or lithotripsy or treatment for stones in the urinary tract. A: Once the treatment is done, there maybe ...

On July 30, 2008, CMS issued its final rule regarding the Hospital Inpatient Prospective Payment System (IPPS). CMS elected to allow healthcare service providers until October 1, 2009 to restructure ...

PAD patients with severe calcification of the external and common iliac arteries who require TAVI can undergo a successful delivery of the device when it is facilitated by pretreatment with ...

Objectives: To review the precautions to be observed before and during extracorporeal shock wave lithotripsy (ESWL) in spinal cord injury (SCI) patients with a cardiac pacemaker and the safety of ...

Please provide your email address to receive an email when new articles are posted on . In patients with calcified peripheral artery lesions treated with a drug-coated balloon, those who were ...

BOSTON--(BUSINESS WIRE)--AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it ...